Octavio Espinoza - 01 Nov 2022 Form 3 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Financial Officer
Signature
/s/ Andrew Reardon, Attorney-in-Fact
Issuer symbol
LGND
Transactions as of
01 Nov 2022
Net transactions value
$0
Form type
3
Filing time
07 Nov 2022, 19:26:02 UTC
Next filing
10 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LGND Common Stock 10,553 01 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 1,883 $80.72 Direct F2
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 1,932 $58.49 Direct F2
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 3,057 $92.65 Direct F2
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 2,074 $70.04 Direct F3
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 546 $70.04 Direct F4
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 3,348 $68.74 Direct F5
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 145 $68.74 Direct F6
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 2,869 $55.75 Direct F7
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 799 $55.75 Direct F8
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 7,171 $57.22 Direct F9
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 691 $57.22 Direct F10
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 4,186 $103.42 Direct F11
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 181 $103.42 Direct F12
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 21,201 $52.84 Direct F13
holding LGND Employee Stock Option (right to buy) 01 Nov 2022 Common Stock 2,166 $52.84 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 7,121 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.
F2 The stock option is fully vested and exercisable.
F3 The stock option vests and is exercisable as to approximately 16% of the underlying shares on August 1, 2019, approximately 74% of the underlying shares in 28 substantially equal monthly installments beginning on September 1, 2019, and approximately 10% of the underlying shares in 12 substantially equal monthly installments thereafter.
F4 The stock option vests in 14 substantially equal monthly installments beginning on January 1, 2022.
F5 The stock option vests and is exercisable as to approximately 13% of the underlying shares on August 11, 2019, and the remaining of the underlying shares in 40 substantially equal monthly installments thereafter.
F6 The stock option vests as to 50% of the underlying shares on January 11, 2023 and as to the remaining on February 11, 2023.
F7 The original grant of 4,039 stock options vests and is exercisable as to approximately 15% of the underlying shares on August 13, 2020, approximately 70% of the underlying shares in 28 substantially equal monthly installments beginning on September 13, 2020, and approximately 15% of the underlying shares in 12 substantially equal monthly installments thereafter.
F8 The stock option vests as to approximately 74.5% of the underlying shares in 12 substantially equal monthly installments beginning on January 13, 2023, and approximately 25.5% of the underlying shares in two substantially equal monthly installments thereafter.
F9 The stock option vests and is exercisable as to approximately 14% of the underlying shares on April 1, 2021, approximately 73% of the underlying shares in 32 substantially equal monthly installments on May 5, 2021, and approximately 13% of the underlying shares in 10 substantially equal monthly installments thereafter.
F10 The stock option vests in 10 substantially similar monthly installments beginning on January 1, 2024.
F11 The stock option is vested and exercisable as to approximately 13% of the underlying shares August 3, 2021, and the remaining of the underlying shares in 40 substantially equal monthly installments thereafter.
F12 The stock option vests as to 50% of the underlying shares on January 3, 2025 and as to the remaining on February 3, 2025.
F13 The stock option vests and is exercisable as to approximately 14% of the underlying shares on August 5, 2022, approximately 64% of the underlying shares in 28 substantially equal monthly installments beginning on September 5, 2022, and approximately 22% of the underlying shares in 12 substantially equal monthly installments thereafter.
F14 The stock option vests as to approximately 55% of the underlying shares in 12 substantially equal monthly installments beginning on January 5, 2025, and approximately 45% of the underlying shares in two substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney.